See also this year's filing and all EDGAR filings for this company.
PDF Report 0000078003_2025_Pfizer_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 6.585479256080115, 'aggregate_val': 63627000000, 'exp_sum': 8388000000, 'exp_to_value': {'remainder_Revenues': 8388000000}} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 5.753615368012087, 'aggregate_val': 62579000000, 'exp_sum': 9266000000, 'exp_to_value': {'remainder_Revenues': 9266000000}} |
Graph
Absolute values for 0000078003, Pfizer INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 50,358,000,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 123,938,000,000 |
| 2 | PropertyPlantAndEquipmentNet | 18,393,000,000 |
| 3 | remainder_Assets | 20,707,000,000 |
| 4 | LiabilitiesCurrent | 42,995,000,000 |
| 5 | LiabilitiesNoncurrent | 71,555,000,000 |
| 6 | remainder_Liabilities | 10,349,000,000 |
| 7 | CostOfGoodsAndServicesSold | 16,537,925,016 |
| 8 | SellingGeneralAndAdministrativeExpense | 14,713,399,971 |
| 9 | ResearchAndDevelopmentExpense | 10,936,599,798 |
| 10 | remainder_Expenses | 7,906,010,869 |
| 11 | remainder_Revenues | 63,886,550,235 |
| 12 | remainder_NetIncome | -3,017,268,412 |
| 13 | remainder_ComprehensiveNetIncome | 179,387,947 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 213,396,000,000 |
| 1 | Liabilities | 124,899,000,000 |
| 2 | Expenses | 50,093,935,654 |
| 3 | Revenues | 63,886,550,235 |
| 4 | StockholdersEquity | 88,497,000,000 |
| 5 | NetIncome | 10,775,346,169 |
| 6 | ComprehensiveNetIncome | 10,865,040,142 |
| 7 | BaseVar | 227,736,071,124 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.20 |
| 9 | EconomicCapitalRatio | 2.46 |
Edgar->Model Mapping
Feature Distribution
Change over Time
